FBRX
Forte BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
FBRX Profile
Forte Biosciences, Inc.
A biotech company that develops and commercializes innovative skin and hair care products
Life Science Tools and Services
--
04/13/2017
NASDAQ Stock Exchange
14
12-31
Common stock
3060 Pegasus Park Drive, Building 6, Dallas, Texas 75247
--
Forte Biosciences, Inc., is a clinical-stage dermatological company dedicated to the development of living biotherapies FB-401 for the treatment of inflammatory skin diseases. FB-401 has completed phase 1/2 a testing in adults and children (3 years and older) with atopic dermatitis. There is a substantial demand for safe and effective therapies, especially for patients with pediatric atopic dermatitis. Forte plans to advance FB-401 into Phase 2 clinical trials in the mid 2020s.
